Elite Pharmaceuticals, Inc. engages in the provision of development and manufacture of pharmacological abuse-deterrent opioid products. It operates through the Abbreviated New Drug Applications and New Drug Applications segments. The ANDA segment includes generic pharmaceuticals. The NDA segment is composed of branded pharmaceuticals. The company was founded on October 1, 1997 and is headquartered in Northvale, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Generic
Employees:
68
Frequently Asked Questions
What is Market Cap of Elite Pharmaceuticals, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Elite Pharmaceuticals, Inc. market cap is $682.74M.
What is the 52-week high for Elite Pharmaceuticals, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Elite Pharmaceuticals, Inc. 52 week high is $0.8194 as of October 03, 2025.
What is the 52-week low for Elite Pharmaceuticals, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Elite Pharmaceuticals, Inc. 52 week low is $0.27 as of October 03, 2025.
What is Elite Pharmaceuticals, Inc. stock price today?
Elite Pharmaceuticals, Inc. stock price today is $0.6375.
What was Elite Pharmaceuticals, Inc. stock price yesterday?
Elite Pharmaceuticals, Inc. stock price yesterday was $0.6647.
What is the PE ratio of Elite Pharmaceuticals, Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Elite Pharmaceuticals, Inc.’s P/E ratio is -63.12.
What is the Price-to-Book ratio of Elite Pharmaceuticals, Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Elite Pharmaceuticals, Inc. P/B ratio is 14.2841.
What is the 50-day moving average of Elite Pharmaceuticals, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Elite Pharmaceuticals, Inc. 50-day moving average is $0.6077.
How many employess does Elite Pharmaceuticals, Inc. has?
